UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

þ		Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

o		Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File No. 1-6651

HILL-ROM HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

Indiana (State or other jurisdiction of incorporation or organization)		35-1160484 (I.R.S. Employer Identification No.)
1069 State Route 46 East
Batesville, Indiana		47006-8835
(Address of principal executive offices)		(Zip Code)

(812) 934-7777
(Registrant’s telephone number, including area code)

Not Applicable
(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes þ      No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes þ      No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act).

Large accelerated filer þ		Accelerated filer o		Non-accelerated filer o		Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes o      No þ

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Common Stock, without par value — 63,101,487 shares as of January 21, 2011.

 

 

HILL-ROM HOLDINGS, INC.

INDEX TO FORM 10-Q

		Page
PART I — FINANCIAL INFORMATION
Item 1 — Financial Statements
Condensed Consolidated Statements of Income (Unaudited) for the Quarterly Periods Ended December 31, 2010 and 2009			3
Condensed Consolidated Balance Sheets (Unaudited) at December 31, 2010 and September 30, 2010			4
Condensed Consolidated Statements of Cash Flows (Unaudited) for the Quarterly Periods Ended December 31, 2010 and 2009			5
Notes to Condensed Consolidated Financial Statements (Unaudited)			6
Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations			16
Item 3 — Quantitative and Qualitative Disclosures About Market Risks			22
Item 4 — Controls and Procedures			22
PART II — OTHER INFORMATION
Item 1 — Legal Proceedings			23
Item 1A — Risk Factors			23
Item 2 — Unregistered Sales of Equity Securities and Use of Proceeds			23
Item 6 — Exhibits			24
SIGNATURES			25
Exhibit 10.6
Exhibit 10.7
Exhibit 10.11
Exhibit 10.12
Exhibit 10.13
Exhibit 31.1
Exhibit 31.2
Exhibit 32.1
Exhibit 32.2
EX-101 INSTANCE DOCUMENT
EX-101 SCHEMA DOCUMENT
EX-101 CALCULATION LINKBASE DOCUMENT
EX-101 LABELS LINKBASE DOCUMENT
EX-101 PRESENTATION LINKBASE DOCUMENT

PART I — FINANCIAL INFORMATION

Item 1.		FINANCIAL STATEMENTS

Hill-Rom Holdings, Inc. and Subsidiaries

(Dollars in millions except per share data)

		Quarterly Period Ended
		December 31,				December 31,
		2010				2009
Net Revenues
Capital sales		$	256.7			$	231.6
Rental revenues			117.5				123.7
Total revenues			374.2				355.3
Cost of Revenues
Cost of goods sold			139.6				130.5
Rental expenses			50.1				54.0
Total cost of revenues			189.7				184.5
Gross Profit			184.5				170.8
Research and development expenses			14.8				14.9
Selling and administrative expenses			120.0				121.6
Operating Profit			49.7				34.3
Interest expense			(2.1	)			(2.1	)
Investment income and other, net			—				0.5
Income Before Income Taxes			47.6				32.7
Income tax expense (Note 9)			12.2				12.8
Net Income			35.4				19.9
Less: Net income attributable to noncontrolling interest			0.2				0.1
Net Income Attributable to Common Shareholders		$	35.2			$	19.8
Net Income Attributable to Common Shareholders per Common Share — Basic		$	0.56			$	0.32
Net Income Attributable to Common Shareholders per Common Share — Diluted		$	0.55			$	0.31
Dividends per Common Share		$	0.1025			$	0.1025
Average Common Shares Outstanding — Basic (thousands) (Note 10)			62,995				62,691
Average Common Shares Outstanding — Diluted (thousands) (Note 10)			64,244				63,205

See Notes to Condensed Consolidated Financial Statements

Hill-Rom Holdings, Inc. and Subsidiaries

(Dollars in millions)

		December 31,				September 30,
		2010				2010
ASSETS
Current Assets
Cash and cash equivalents		$	182.4			$	184.5
Trade accounts receivable, net of allowances (Note 2)			352.1				353.1
Inventories (Note 2)			112.9				108.5
Deferred income taxes (Notes 1 and 9)			40.5				40.4
Other current assets			42.7				52.7
Total current assets			730.6				739.2
Property, plant and equipment, net (Note 2)			233.9				243.7
Investments and investment securities (Notes 1 and 6)			11.8				12.1
Goodwill			81.1				81.1
Software and other intangible assets, net (Note 2)			134.2				136.6
Other assets			32.0				32.9
Total Assets		$	1,223.6			$	1,245.6
LIABILITIES
Current Liabilities
Trade accounts payable		$	67.9			$	80.6
Short-term borrowings (Note 4)			108.3				53.1
Accrued compensation			63.0				88.9
Accrued product warranties (Note 12)			16.0				15.8
Other current liabilities			47.8				50.3
Total current liabilities			303.0				288.7
Long-term debt (Note 4)			50.0				98.5
Accrued pension and postretirement benefits (Note 5)			58.6				59.0
Deferred income taxes (Notes 1 and 9)			26.0				31.3
Other long-term liabilities			57.2				52.3
Total Liabilities			494.8				529.8
Noncontrolling interest (Note 3)			—				8.3
Commitments and Contingencies (Note 14)
SHAREHOLDERS’ EQUITY
Common Stock			4.4				4.4
Additional paid-in-capital			108.6				119.3
Retained earnings			1,232.3				1,203.6
Accumulated other comprehensive loss (Note 7)			(61.6	)			(61.8	)
Treasury stock, at cost (Notes 2 and 11)			(554.9	)			(558.0	)
Total Shareholders’ Equity			728.8				707.5
Total Liabilities, Non-Controlling Interest and Shareholders’ Equity		$	1,223.6			$	1,245.6

See Notes to Condensed Consolidated Financial Statements.

Hill-Rom Holdings, Inc. and Subsidiaries

(Dollars in millions)

		Quarterly Period Ended
		December 31,				December 31,
		2010				2009
Operating Activities
Net income		$	35.4			$	19.9
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization			25.4				24.4
Provision for deferred income taxes			(1.6	)			(5.4	)
Loss on disposal of property, equipment leased to others, intangible assets and impairments			(0.1	)			0.8
Stock compensation			2.6				3.6
Excess tax benefits from employee stock plans			(3.6	)			—
Change in working capital excluding cash, current investments, current debt, acquisitions and dispositions:
Trade accounts receivable			1.7				4.2
Inventories			(4.3	)			(2.2	)
Other current assets			11.3				(4.4	)
Trade accounts payable			(12.8	)			(11.4	)
Accrued expenses and other liabilities			(31.0	)			(7.4	)
Other, net			0.5				(0.5	)
Net cash provided by operating activities			23.5				21.6
Investing Activities
Capital expenditures and purchase of intangibles			(12.5	)			(11.6	)
Proceeds on sales of property and equipment leased to others			2.1				0.1
Acquisitions of businesses, net of cash acquired			—				(7.1	)
Proceeds on investment sales/maturities			0.2				0.5
Net cash used in investing activities			(10.2	)			(18.1	)
Financing Activities
Change in short-term debt			7.0				1.6
Payment on revolver			—				(45.0	)
Purchase of noncontrolling interest			(10.6	)			—
Payment of cash dividends			(6.5	)			(6.4	)
Proceeds on exercise of options			19.1				0.2
Proceeds from stock issuance			0.8				0.7
Excess tax benefits from employee stock plans			3.6				—
Treasury stock acquired			(28.8	)			(0.8	)
Net cash used in financing activities			(15.4	)			(49.7	)
Effect of exchange rate changes on cash			—				(0.6	)
Total Cash Flows			(2.1	)			(46.8	)
Cash and Cash Equivalents:
At beginning of period			184.5				170.6
At end of period		$	182.4			$	123.8

See Notes to Condensed Consolidated Financial Statements

Hill-Rom Holdings, Inc. and Subsidiaries

(Dollars in millions except per share data)

1. Summary of Significant Accounting Policies

Basis of Presentation

The unaudited, Condensed Consolidated Financial Statements appearing in this Quarterly Report on Form 10-Q (“Form 10-Q”) should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s latest Annual Report on Form 10-K for the fiscal year ended September 30, 2010 (“2010 Form 10-K”) as filed with the U.S. Securities and Exchange Commission (“SEC”). Unless the context otherwise requires, the terms “Hill-Rom,” “the Company,” “we,” “our” and “us” refer to Hill-Rom Holdings, Inc. and its majority-owned subsidiaries. The September 30, 2010 Consolidated Balance Sheet data was derived from audited consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“U.S.”). In the opinion of management, the Condensed Consolidated Financial Statements herein include all adjustments, consisting only of normal recurring adjustments, necessary to state fairly the financial position, results of operations and cash flows for the interim periods presented. Quarterly results are not necessarily indicative of annual results.

Principles of Consolidation

The Condensed Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All subsidiaries are wholly-owned as of December 31, 2010. During our first quarter we acquired the remaining 40 percent noncontrolling interest in our former joint venture (see Note 3). Intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of certain assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reporting period. Actual results could differ from those estimates. Examples of such estimates include our accounts receivable reserves (Note 2), investments (Note 6), income taxes (Note 9), accrued warranties (Note 12) and accrued litigation and self insurance reserves (Note 14), among others.

Investment Securities

At December 31, 2010, investment securities consisted primarily of $11.6 million in AAA rated student loan auction rate securities (“ARS”). These securities are generally insured through the U.S. government’s Federal Family Education Loan Program, to the extent the borrowers meet certain prescribed criteria in their underlying lending practices. These securities are classified as available-for-sale and changes in their fair value are recorded in Accumulated Other Comprehensive Loss (“AOCL”).

We regularly evaluate all investments classified as available-for-sale for possible impairment based on current economic conditions, credit loss experience and other criteria. The evaluation of investments for impairment requires significant judgments to be made including (i) the identification of potentially impaired securities; (ii) the determination of their estimated fair value; (iii) the assessment of whether any decline in estimated fair value is other-than-temporary; and (iv) the likelihood of selling before recovery. If there is a decline in a security’s net realizable value that is other-than-temporary, the decline is separated into the amount of impairment related to credit loss and the amount of impairment related to all other factors. The decline related to the credit loss is recognized in earnings, while the decline related to all other factors is recognized in AOCL.

Taxes Collected from Customers and Remitted to Governmental Units

Taxes assessed by a governmental authority that are directly imposed on a revenue producing transaction between us and our customers, including but not limited to sales taxes, use taxes and value added taxes, are accounted for on a net (excluded from revenues and costs) basis.

Income Taxes

The Company and its eligible domestic subsidiaries file a consolidated U.S. income tax return. Foreign operations file income tax returns in a number of jurisdictions. Deferred income taxes are computed using an asset and liability approach to reflect the net tax effects of temporary differences between the financial reporting carrying amounts of assets and liabilities and the corresponding income tax amounts. We have a variety of deferred tax assets in numerous tax jurisdictions. These deferred tax assets are subject to periodic assessment as to recoverability and if it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recognized. In evaluating whether it is more likely than not that we would recover these deferred tax assets, future taxable income, the reversal of existing temporary differences and tax planning strategies are considered.

We believe that our estimates for the valuation allowances recorded against deferred tax assets are appropriate based on current facts and circumstances. Entering the year we had $28.5 million of valuation allowances on deferred tax assets, on a tax-effected basis, primarily related to foreign operating loss carryforwards and other tax attributes. It is possible that sustainable improvements in foreign earnings could result in a reconsideration of the need for these valuation allowances, resulting in the accelerated recognition of all or some portion of the previously unrecognized tax benefits.

We account for uncertain income tax positions using a threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The difference between the tax benefit recognized in the financial statements for an uncertain income tax position and the tax benefit claimed in the tax return is referred to as an unrecognized tax benefit.

Recently Issued Accounting Standards

There have been no significant changes to our assessment of the impact of recently issued accounting standards included in Note 1 of Notes to Consolidated Financial Statements in our 2010 Form 10-K except as noted below:

On October 1, 2010 we adopted the Financial Accounting Standard Board’s (“FASB”) revised authoritative guidance requiring entities to provide more information about sales of securitized financial assets and similar transactions, particularly if the seller retains some risk with respect to the assets. Our adoption of this guidance was prospective and did not have a material impact on our condensed consolidated financial statements.

On October 1, 2010, we adopted the FASB’s revised authoritative guidance to improve financial reporting for companies involved with variable interest entities to provide more relevant and reliable information to users of financial statements. Our adoption of this guidance was prospective and did not have a material impact on our consolidated financial statements.

2. Supplementary Balance Sheet Information

		December 31,				September 30,
		2010				2010
Allowance for possible losses and discounts on trade receivables		$	28.3			$	29.0
Inventories:
Finished products		$	66.6			$	64.2
Raw materials and work in process			46.3				44.3
Total inventory		$	112.9			$	108.5
Accumulated depreciation of property, plant and equipment		$	568.2			$	561.3
Accumulated amortization of software and other intangible assets		$	144.8			$	137.8
Preferred stock, without par value:
Shares authorized			1,000,000				1,000,000
Shares issued		None				None
Common stock, without par value:
Shares authorized			199,000,000				199,000,000
Shares issued			80,323,912				80,323,912
Shares outstanding			63,087,835				62,786,883
Treasury shares			17,236,077				17,537,029

3. Acquisitions

On November 9, 2009, the Company entered into a joint venture with Encompass Group, LLC (“Encompass Group”), a leader in health care textiles and therapeutic and prevention surfaces, to form Encompass TSS, LLC (“Encompass”), of which we ultimately owned 60 percent. For our 60 percent ownership interest we paid $7.5 million to Encompass Group, contributed cash and entered into license and distribution agreements with Encompass. On November 30, 2010, we purchased the remaining 40 percent of Encompass for $10.6 million, plus a variable earn-out with a minimum of $1.2 million and a maximum of $1.6 million per year over five years. We have a total of $6.0 million accrued in other current liabilities and other long-term liabilities on our Condensed Consolidated Balance Sheet at December 31, 2010 related to the earn-out.

If the Encompass joint venture had been consummated at the beginning of our 2010 fiscal year or wholly-owned, the impact to revenues and net income on an unaudited pro forma basis would not have been significant to our financial results in any of the periods presented.

4. Financing Agreements

Total debt consists of the following:

		December 31, 2010				September 30, 2010
Outstanding finance credit lines		$	15.1			$	8.1
Revolving credit facility			45.0				45.0
Unsecured 8.50% debentures due on December 1, 2011			48.2				48.4
Unsecured 7.00% debentures due on February 15, 2024			19.7				19.7
Unsecured 6.75% debentures due on December 15, 2027			29.8				29.8
Other			0.5				0.6
Total debt			158.3				151.6
Less current portion of debt			108.3				53.1
Total long-term debt		$	50.0			$	98.5

We have trade finance credit lines and uncommitted letter of credit facilities. These lines are associated with the normal course of business and are not currently, nor have they historically, been of material size to the overall business.

Unsecured debentures outstanding at December 31, 2010 have fixed rates of interest. We have deferred gains included in the amounts above from the termination of previous interest rate swap agreements, and those deferred gains amounted to $1.8 million at December 31, 2010 and $2.1 million at September 30, 2010. The deferred gains on the termination of the swaps are being amortized and recognized as a reduction of interest expense over the remaining term of the related debt through 2011 and 2024, and as a result, the effective interest rates on that debt have been and will continue to be lower than the stated interest rates on the debt.

The Company has a $500.0 million senior revolving credit facility, which expires on March 28, 2013 (subject to extension upon satisfaction of certain conditions set forth in the credit facility). Borrowings under the credit facility bear interest at variable rates, and the availability of borrowings is subject to our ability at the time of borrowing to meet certain specified conditions, including compliance with covenants contained in the credit agreement governing the facility. The credit agreement contains covenants that, among other matters, require the Company to maintain a ratio of consolidated indebtedness to consolidated EBITDA (each as defined in the credit agreement) of not more than 3.5:1.0 and a ratio of consolidated EBITDA to interest expense of not less than 3.5:1.0. The proceeds of the five-year facility shall be used, as needed: (i) for working capital, capital expenditures, and other lawful corporate purposes; and (ii) to finance acquisitions.

As of December 31, 2010, we had outstanding borrowings of $45.0 million and undrawn letters of credit of $5.8 million under the five-year facility, leaving $449.2 million of borrowing capacity available under the facility.

The fair value of our debt is estimated based on the quoted market prices for the same or similar issues or on the current rates offered to us for debt of the same remaining maturities. The book values of our short-term debt instruments approximate fair value. The estimated fair values of our long-term debt instruments were $53.8 and $95.7 million at December 31, 2010 and September 30, 2010.

5. Retirement and Postretirement Plans

The Company sponsors four defined benefit plans: a master defined benefit retirement plan, a nonqualified supplemental executive defined benefit retirement plan and two defined benefit retirement plans covering employees in Germany and France. Benefits for such plans are based primarily on years of service and the employee’s level of compensation during specific periods of employment. We contribute funds to trusts as necessary to provide for current service and for any unfunded projected future benefit obligation over a reasonable period of time. All of our plans have a September 30th measurement date. The following table includes the components of net pension expense for our defined benefit plans.

		Quarterly Period Ended
		December 31,				December 31,
		2010				2009
Service cost		$	1.3			$	1.3
Interest cost			3.3				3.3
Expected return on plan assets			(4.2	)			(3.3	)
Amortization of unrecognized prior service cost, net			0.2				0.1
Amortization of net loss			1.0				0.7
Net pension expense		$	1.6			$	2.1

The Company also sponsors a domestic postretirement health care plan that provides health care benefits to qualified retirees and dependents until eligible for Medicare. Annual costs related to the domestic postretirement health care plan are not significant.

6. Fair Value Measurements

Fair value measurements are classified and disclosed in one of the following three categories:

•

Level 1: Financial instruments with unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets and liabilities.

•

Level 2: Financial instruments with observable inputs other than those included in Level 1 such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

•

Level 3: Financial instruments with unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Unobservable inputs reflect the Company’s own assumptions that market participants would use in pricing the asset or liability (including assumptions about risk). Unobservable inputs shall be developed based on the best information available in the circumstances, which might include the Company’s own data.

The following table summarizes the Company’s financial assets measured at fair value on a recurring basis included in our Condensed Consolidated Balance Sheet, as of December 31, 2010:

						Fair Value Measurements
						Quoted Prices in				Significant Other				Significant
						Active Markets for				Observable				Unobservable
						Identical Assets				Inputs				Inputs
		Total				(Level 1)				(Level 2)				(Level 3)
Assets:
Cash and cash equivalents		$	182.4			$	182.4			$	—			$	—
Available-for-sale marketable securities			11.6				—				—				11.6
Other investments			0.2				—				—				0.2
Total assets at fair value		$	194.2			$	182.4			$	—			$	11.8

At December 31, 2010, we had $11.6 million of AAA rated student loan ARS. While we continue to earn interest on the ARS at the contractual rate, these investments are not currently being bought and sold in an active market and therefore do not have readily determinable market values. At December 31, 2010, the Company’s investment advisors provided a valuation based on unobservable inputs for the ARS. The investment advisors utilized a discounted cash flow approach (an “income approach”) to arrive at this valuation, which was corroborated by separate and comparable discounted cash flow analysis prepared by us. The assumptions used in preparing the discounted cash flow model include estimates of interest rates, timing and amount of cash flows, credit spread related yield and illiquidity premiums and expected holding periods of the ARS. These assumptions are volatile and subject to change as the underlying sources of these assumptions and market conditions change. Activity related to our ARS was not significant during our first quarter.

7. Comprehensive Income

The net-of-tax effect of unrealized gains or losses on: our available-for-sale securities, foreign currency translation adjustments, pension (or other defined benefit postretirement plans’) actuarial gains or losses, prior service costs or credits are required to be included in comprehensive income.

The composition of comprehensive income is as follows:

		Quarterly Period Ended
		December 31,				December 31,
		2010				2009
Net income		$	35.4			$	19.9
Net gain on available-for-sale securities and other investments			—				0.1
Foreign currency translation adjustment, net-of-tax			0.4				(3.0	)
Items not yet recognized as a component of net periodic pension or postretirement benefit cost, net-of-tax			(0.2	)			(0.1	)
Total comprehensive income			35.6				16.9
Comprehensive income attributable to the noncontrolling interest			(0.2	)			(0.1	)
Total comprehensive income attributable to common shareholders		$	35.4			$	16.8

8. Special Charges

Over the past several years, the Company has placed a focus on improving our cost structure and business processes through various means including consolidation of certain manufacturing and select back office operations, customer rationalizations and various other organizational changes. Activity related to these actions during the first quarter of fiscal 2011 was as follows:

		Beginning																Ending
		Balance																Balance
		September 30,																December 31,
		2010				Expenses				Cash Payments				Reversals				2010
Fiscal Year 2010
Q2 Action — Restructuring		$	1.5			$	—			$	(0.7	)		$	—			$	0.8
Q4 Action — Restructuring			3.7				—				(0.8	)			—				2.9
Total Fiscal Year 2010		$	5.2			$	—			$	(1.5	)		$	—			$	3.7

9. Income Taxes

The effective tax rate for the first quarter of fiscal 2011 was 25.6 percent compared to 39.2 percent for the first quarter of 2010. The effective tax rate for the three months ended December 31, 2010 was favorably impacted by the recognition of current period tax benefits of $2.1 million relating primarily to the one-time “catch up” associated with the retroactive reinstatement of the research and development tax credit. Also favorably impacting the rate were increased earnings in lower-rate jurisdictions, including improved European income, some of which was not subject to tax as a result of the utilization of previously unrecognized operating loss carryforwards. We currently carry full valuation allowances on these loss carryforwards, thus the recognition of income and the release of valuation allowance results in no tax expense on the earnings. It is possible that sustainable improvements in foreign earnings could result in a reconsideration of the need for these valuation allowances, resulting in the accelerated recognition of all or some portion of the previously unrecognized tax benefits.

10. Earnings per Common Share

Basic earnings per share are calculated based upon the weighted average number of outstanding common shares for the period, plus the effect of deferred vested shares. Diluted earnings per share are calculated consistent with the basic earnings per share calculation plus the effect of dilutive unissued common shares related to stock-based employee compensation programs. For all periods presented, anti-dilutive stock options were excluded from the calculation of diluted earnings per share. Excluded shares were 0.5 million for the period ended December 31, 2010, and 4.4 million for the comparable period of fiscal year 2010. Cumulative treasury stock acquired, less cumulative shares reissued, have been excluded in determining the average number of shares outstanding.

Earnings per share is calculated as follows (share information in thousands):

		Quarterly Period Ended
		December 31,				December 31,
		2010				2009
Net income attributable to common shareholders		$	35.2			$	19.8
Average shares outstanding — Basic			62,995				62,691
Add potential effect of exercise of stock options and other unvested equity awards			1,249				514
Average shares outstanding — Diluted			64,244				63,205
Net income attributable to common shareholders per common share — Basic		$	0.56			$	0.32
Net income attributable to common shareholders per common share — Diluted		$	0.55			$	0.31

11. Common Stock

Share Repurchases

Our Board of Directors has approved the repurchase of a total of 25.7 million shares of our common stock through the open market or private transactions. During the quarter ended December 31, 2010, we repurchased 0.6 million shares of our common stock for $25.2 million. As of December 31, 2010, a cumulative total of 24.3 million shares had been repurchased by us at market trading prices, leaving approximately 1.4 million shares still available for repurchase. The Board’s approval has no expiration date and currently there are no plans to terminate this program in the future.

Stock Based Compensation

The stock based compensation cost that was charged against income, net of tax, for all plans was $1.6 million for the quarterly period ended December 31, 2010 and $2.2 million for the comparable period of fiscal year 2010.

12. Guarantees

We routinely grant limited warranties on our products with respect to defects in material and workmanship. The terms of these warranties are generally one year, however, certain components and products have substantially longer warranty periods. We recognize a reserve with respect to these obligations at the time of product sale, with subsequent warranty claims recorded directly against the reserve. The amount of the warranty reserve is determined based on historical trend experience for the covered products. For more significant warranty-related matters which might require a broad-based correction, separate reserves are established when such events are identified and the cost of correction can be reasonably estimated.

A reconciliation of changes in the warranty reserve for the periods covered in this report is as follows:

		Quarterly Period Ended
		December 31,				December, 31
		2010				2009
Balance at beginning of period		$	15.8			$	17.1
Provision for warranties during the period			4.2				3.0
Warranty claims during the period			(4.0	)			(4.7	)
Balance at end of period		$	16.0			$	15.4

In the normal course of business we enter into various other guarantees and indemnities in our relationships with suppliers, service providers, customers, business partners and others. Examples of these arrangements would include guarantees of product performance, indemnifications to service providers and indemnifications of our actions to business partners. These guarantees and indemnifications have not historically nor do we expect them to have a material impact on our financial condition or results of operations, although indemnifications associated with our actions generally have no dollar limitations.

In conjunction with our acquisition and divestiture activities, we have entered into select guarantees and indemnifications of performance with respect to the fulfillment of commitments under applicable purchase and sale agreements. The arrangements generally indemnify the buyer or seller for damages associated with breach of contract, inaccuracies in representations and warranties surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract. For those representations and warranties that survive closing, they generally survive for periods up to five years or the expiration of the applicable statutes of limitations. Potential losses under the indemnifications are generally limited to a portion of the original transaction price, or to other lesser specific dollar amounts for select provisions. With respect to sale transactions, we also routinely enter into non-competition agreements for varying periods of time. Guarantees and indemnifications with respect to acquisition and divestiture activities, if triggered, could have a materially adverse impact on our financial condition and results of operations.

13. Segment Reporting

We disclose segment information that is consistent with the way in which management operates and views the Company. During the first quarter of fiscal 2011, we changed our segment reporting to reflect changes in our organizational structure and management’s view of the Company. We moved our surgical reporting unit from the International and Surgical segment (now referred to as the International segment) to the North America Acute Care segment. In addition, manufacturing and research and development costs were further allocated to the segments such that all manufacturing and research and development costs are now included in divisional income. We have also assigned additional direct functional costs to the segments as well as an allocation of certain corporate functional expenses that can be attributed to the segments. The prior year segment information included in this Note has been updated to reflect these changes. Our new operating structure contains the following reporting segments:

•

North America Acute Care — sells and rents our hospital patient support and near-patient technologies, as well as our health information technology solutions and surgical accessories, to acute care facilities.

•

North America Post-Acute Care — sells and rents a variety of products outside of the hospital setting including long-term acute care, extended care and home care, offering patient support systems and respiratory care products.

•

International — sells and rents similar products as our North America businesses to Europe and the rest of the world.

Under our new segments the Company’s performance under each reportable segment continues to be measured on a divisional income basis before special items. Divisional income generally represents the division’s standard gross profit less its direct operating costs along with an allocation of manufacturing and distribution costs, research and development and corporate functional expenses.

Corporate expenses, while not considered a segment, are presented separately to aid in the reconciliation of segment information to consolidated financial information. These costs include corporate costs that support the entire organization such as administration, finance, legal and human resources.

		Quarterly Period Ended
		December 31,				December 31,
		2010				2009
Revenues:
North America Acute Care		$	218.1			$	205.6
North America Post-Acute Care			52.3				52.6
International			103.8				97.1
Total revenues		$	374.2			$	355.3
Divisional income:
North America Acute Care		$	44.6			$	37.4
North America Post-Acute Care			12.2				12.8
International			10.5				0.6
Corporate expenses			(17.6	)			(16.5	)
Total divisional income			49.7				34.3
Interest expense			(2.1	)			(2.1	)
Investment income and other, net			—				0.5
Income before income taxes		$	47.6			$	32.7

14. Commitments and Contingencies

Batesville Casket Antitrust Litigation

In 2005 the Funeral Consumers Alliance, Inc. and a number of individual consumer casket purchasers (“FCA Action”) filed a purported class action antitrust lawsuit on behalf of certain consumer purchasers of Batesville^® caskets against the Company and its former Batesville Casket Company, Inc. subsidiary (now wholly-owned by Hillenbrand, Inc.), and three national funeral home businesses.

The district court has dismissed the claims and denied class certification, but in October 2010, these decisions were appealed to the United States Court of Appeals for the Fifth Circuit. If the plaintiffs were to succeed in reversing the district court’s dismissal of the claims, but not the denial of class certification, then the plaintiffs would be able to pursue individual damages claims: the alleged overcharges on the plaintiffs’ individual casket purchases, which would be trebled as a matter of law, plus reasonable attorneys fees and costs.

If the plaintiffs were to (1) succeed in reversing the district court’s dismissal of the claims, (2) succeed in reversing the district court order denying class certification and certify a class, and (3) prevail at trial, then the damages awarded to the plaintiffs, which would be trebled as a matter of law, could have a significant material adverse effect on our results of operations, financial condition and/or liquidity. The plaintiffs in the FCA Action filed a report indicating that they are seeking damages ranging from approximately $947.0 million to approximately $1.46 billion before trebling on behalf of the purported class of consumers they seek to represent, based on claims of approximately one million casket purchases by the purported class members.

We and Hillenbrand, Inc. have entered into a Judgment Sharing Agreement that apportions the costs and any potential liabilities associated with this litigation between us and Hillenbrand, Inc.

We believe that we have committed no wrongdoing as alleged by the plaintiffs and that we have meritorious defenses to class certification and to plaintiffs’ underlying allegations and damage theories.

Office of Inspector General Investigation

On February 8, 2008, we were served with an Administrative Investigative Demand subpoena by the United States Attorney’s Office for the Eastern District of Tennessee pursuant to a Health and Human Services’ Office of Inspector General investigation. On September 18, 2008, we were informed that the investigation was precipitated by the filing in 2005 of a qui tam (whistleblower) complaint under the False Claims Act in the United States District Court for the Eastern District of Tennessee. Once the complaint is filed with the court under seal, the Department of Justice investigates the allegations and has the right to intervene and in effect take over the prosecution of the lawsuit if it believes the allegations warrant. At this point, the government has not yet reached a final intervention decision and is continuing its investigation.

Although the complaint has been only partially unsealed at this point and we have not been formally served, we know that the plaintiffs seek recovery of significant damages and civil penalties relating to the alleged submission of false and fraudulent claims to Medicare and/or Medicaid for the provision of durable medical equipment. In the event that this matter were to proceed to litigation, if it were found that we had failed to comply with applicable laws and regulations, we could be subject to substantial fines or penalties and possible exclusion from participation in federal health care programs. At this time, we are continuing to cooperate with the government’s investigation. We cannot provide any assurances as to when the government will finish its investigation, or when, if ever, it will determine to formally intervene.

Freedom Medical Antitrust Litigation

On October 19, 2009, Freedom Medical, Inc. filed a complaint against the Company, another manufacturer and two group purchasing organizations in the United States District Court for the Eastern District of Texas. The plaintiff alleges that the Company and the other defendants conspired to exclude it from the biomedical equipment rental market and to maintain the Company’s market share by engaging in a variety of conduct in violation of state and federal antitrust laws. The plaintiff also has asserted claims for business disparagement, common law conspiracy and tortuous interference with business relationships. The plaintiff seeks injunctive relief and money damages in an unspecified amount. We intend to defend this matter vigorously. Because the litigation is in a preliminary stage, we cannot assess the likelihood of an adverse outcome or determine an estimate, or a range of estimates, of potential damages, nor can we give any assurances that this matter will not have a material adverse impact on the Company’s financial condition, results of operations or cash flows.

General

We are subject to various other claims and contingencies arising out of the normal course of business, including those relating to governmental investigations and proceedings, commercial transactions, product liability, employee related matters, antitrust, safety, health, taxes, environmental and other matters. Litigation is subject to many uncertainties and the outcome of individual litigated matters is not predictable with assurance. It is possible that some litigation matters for which reserves have not been established could be decided unfavorably to us, and that any such unfavorable decisions could have a material adverse effect on our financial condition, results of operations and cash flows.

We are involved in possible claims and are generally self-insured up to certain limits for product/general liability, workers’ compensation, auto liability and professional liability insurance programs. These policies have deductibles and self-insured retentions ranging from $150 thousand to $1.5 million per occurrence, depending upon the type of coverage and policy period. We are also generally self-insured up to certain stop-loss limits for certain employee health benefits, including medical, drug and dental. Our policy is to estimate reserves based upon a number of factors including known claims, estimated incurred but not reported claims and outside actuarial analysis, which are based on historical information along with certain assumptions about future events.

Item 2.		MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements and Factors That May Affect Future Results

Certain statements in this Quarterly Report on Form 10-Q contain forward-looking statements within the meanings of the Private Securities Litigation Reform Act of 1995 regarding our future plans, objectives, beliefs, expectations, representations and projections. We have tried, whenever possible, to identify these forward-looking statements by using words such as “intend,” “anticipate,” “believe,” “plan,” “encourage,” “expect,” “may,” “goal,” “become,” “pursue,” “estimate,” “strategy,” “will,” “projection,” “forecast,” “continue,” “accelerate,” “promise,” “increase,” “higher,” “lower,” “reduce,” “improve,” “expand,” “progress,” “potential” or the negative of those terms or other variations of them or by comparable terminology. The absence of such terms, however, does not mean that the statement is not forward-looking.

Forward-looking statements are not guarantees of future performance, and our actual results could differ materially from those set forth in any forward-looking statements. Factors that could cause actual results to differ from forward-looking statements include but are not limited to the factors discussed under the heading “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended September 30, 2010 (“2010 Form 10-K”) as well as the discussions in this “Management’s Discussion and Analysis”. We assume no obligation to update or revise any forward-looking statements.

Overview

The following discussion and analysis should be read in conjunction with the accompanying interim financial statements and “Managements Discussion and Analysis of Financial Conditions and Results of Operations” included in our 2010 Form 10-K.

Hill-Rom Holdings, Inc. (the “Company,” “we,” “us,” or “our”) is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals and information technology solutions. Our comprehensive product and service offerings are used by health care providers across the health care continuum in hospitals, extended care facilities and home care settings worldwide, to enhance the safety and quality of patient care.

Use of Non-GAAP Financial Measure

These condensed consolidated financial statements, including the related notes, are presented in accordance with accounting principles generally accepted in the U.S. (GAAP). The Company analyzes net revenues on a constant currency basis to better measure the comparability of results between periods. We believe that evaluating growth in net revenues on a constant currency basis provides an additional and meaningful assessment to both management and investors.

We believe use of this non-GAAP measure contributes to an understanding of our financial performance and provides an additional analytical tool to understand our results from core operations and to reveal underlying trends. It should not, however, be considered in isolation, as a substitute for, or as superior to measures of financial performance prepared in accordance with GAAP.

Consolidated Results of Operations

In this section, we provide a high-level overview of our consolidated results of operations. Immediately following this section is a discussion of our results of operations by reportable segment.

Net Revenues

		Quarterly Period Ended								Percentage Change
		December 31,				December 31,								Constant
(Dollars in millions)		2010				2009				As Reported				Currency
Revenues:
Capital sales		$	256.7			$	231.6				10.8				12.0
Rental revenues			117.5				123.7				(5.0	)			(4.4	)
Total Revenues		$	374.2			$	355.3				5.3				6.3

Capital sales increased as a result of North America Acute Care sales volume growth in several major product categories led by patient support systems (increased 22.4 percent) as well as continued volume growth internationally in the Middle East, Latin America and Asia. Volume increases were offset by modestly unfavorable pricing.

Rental revenues declined in the first quarter due to volume declines in our therapy rental business as well as declines in rentals of our movable medical equipment fleet associated with a weaker flu season compared to fiscal 2010.

Gross Profit

		Quarterly Period Ended
		December 31,				December 31,
(Dollars in millions)		2010				2009
Gross Profit
Capital		$	117.1			$	101.1
Percent of Related Revenues			45.6	%			43.7	%
Rental			67.4			$	69.7
Percent of Related Revenues			57.4	%			56.3	%
Total Gross Profit		$	184.5			$	170.8
Percent of Related Revenues			49.3	%			48.1	%

Consolidated gross profit increased 8.0 percent and increased as a percentage of revenues by 120 basis points.

Capital gross profit increased 15.8 percent and gross margin (as a percentage of revenues) increased 190 basis points. The gross margin increase was primarily due to an improved mix towards higher margin products as well as favorable material and manufacturing costs.

Rental gross profit decreased 3.3 percent, while gross margin increased 110 basis points. The increase in gross margin for the quarter was due to cost improvements within our field service network.

Other

		Quarterly Period Ended
		December 31,				December 31,
(Dollars in millions)		2010				2009
Research and development expenses		$	14.8			$	14.9
Percent of Total Revenues			4.0	%			4.2	%
Selling and administrative expenses		$	120.0			$	121.6
Percent of Total Revenues			32.1	%			34.2	%
Interest expense		$	(2.1	)		$	(2.1	)
Investment income		$	0.5			$	0.6
Other		$	(0.5	)		$	(0.1	)

Research and development expenses were flat for the quarter and declined as a percentage of sales due to timing of project spending and the higher revenues experienced in the first quarter of fiscal 2011. Selling and administrative expenses were slightly favorable for the quarter and improved as a percentage of sales by 210 basis points. The decline was a result of benefits realized from previously announced restructuring activities and the impact of cost reduction initiatives.

Interest expense is consistent year over year due to consistent interest rates and a consistent total debt balance. Investment income also remained consistent year over year, the result of a higher cash balance in fiscal 2011, offset by lower interest rates.

The effective tax rate for the first quarter of fiscal 2011 was 25.6 percent compared to 39.2 percent for the first quarter of 2010. The lower rate in the first quarter of fiscal 2011 was due primarily to the impact of the retroactive reinstatement of the research and development tax credit back to January 1, 2010, the impact of increased earnings in lower tax rate jurisdictions and the effects of the research and development credit on projected fiscal 2011 earnings.

Increased earnings in lower-rate jurisdictions included improved European income, some of which was not subject to tax as a result of the utilization of previously unrecognized operating loss carryforwards. We currently carry full valuation allowances on these loss carryforwards, thus the recognition of income and the release of valuation allowance results in no tax expense on the earnings. It is possible that sustainable improvements in foreign earnings could result in a reconsideration of the need for these valuation allowances, resulting in the accelerated recognition of all or some portion of the previously unrecognized tax benefits. Should this occur, the future income in the affected jurisdictions would be subject to tax at their normal statutory tax rates, resulting in an increase in our overall effective tax rate in future periods.

Net income attributable to common shareholders was $35.2 million for the first quarter of fiscal 2011, representing an increase of 77.8 percent. Diluted earnings per share increased 77.4 percent for the quarter to $0.55.

Business Segment Results of Operations

During the first quarter of fiscal 2011, we changed our segment reporting to reflect changes in our organizational structure and management’s view of the Company. We moved our surgical reporting unit from the International and Surgical segment (now referred to as the International segment) to the North America Acute Care segment. In addition, manufacturing and research and development costs were further allocated to the segments such that all manufacturing and research and development costs are now included in divisional income. We have also assigned additional direct functional costs to the segments as well as an allocation of certain corporate functional expenses that can be attributed to the segments. The prior year segment information below has been updated to reflect these changes.

		Quarterly Period Ended								Percentage Change
		December 31,				December 31,								Constant
(Dollars in millions)		2010				2009				As Reported				Currency
Revenues:
North America Acute Care		$	218.1			$	205.6				6.1				5.8
North America Post-Acute Care			52.3				52.6				(0.6	)			(0.6	)
International			103.8				97.1				6.9				11.0
Total revenues		$	374.2			$	355.3				5.3				6.3
Divisional income:
North America Acute Care		$	44.6			$	37.4				19.3
North America Post-Acute Care			12.2				12.8				(4.7	)
International			10.5				0.6				1650.0
Corporate Expenses			(17.6	)			(16.5	)			(6.7	)
Total divisional income		$	49.7			$	34.3				44.9

North America Acute Care

North America Acute Care capital sales increased 12.3 percent mainly due to higher volumes in several of our major product categories led by our patient support systems, which increased 22.4 percent. The volume increases were partially offset by modestly unfavorable price and product mix. Rental revenues decreased by 6.5 percent due primarily to a decline in therapy rentals as well as rentals of moveable medical equipment driven by a weaker flu season compared to fiscal 2010.

North America Acute Care divisional income increased due to an increase in total gross profit and margin improvements driven by higher capital volumes, improved material and manufacturing costs and cost improvements within our field service network, partially offset by lower pricing. Research and development costs along with selling and administrative costs were relatively flat during the first quarter.

North America Post-Acute Care

North America Post-Acute Care capital sales decreased by 2.6 percent related to a decline in sales within our extended care business partially offset by growth in The Vest^® respiratory care system and home care direct to consumer business. Rental revenues were flat year over year.

North America Post-Acute Care divisional income decreased due to higher operating expenses, primarily related to investments in our sales channels. Total gross profit and margins were essentially flat year over year.

International

International capital sales increased 10.4 percent, and 14.1 percent on a constant currency basis. On a constant currency basis, the increase was driven by growth in the Middle East, Latin America and Asia due primarily to favorable volume, partially offset by flat revenues in Europe. Rental revenues decreased 12.0 percent and 6.0 percent on a constant currency basis. The decline in rental revenues can be attributed mainly to the rationalization of unprofitable business.

International divisional income increased significantly due to an increase in gross profit and margins as well as a decrease in operating expenses. The increase in gross margin was due to favorable product and geographic mix. Operating expenses decreased related to favorable exchange rates on costs as well as reduced costs from previous restructuring actions.

Liquidity and Capital Resources

		Quarterly Period Ended
		December 31,				December 31,
(Dollars in millions)		2010				2009
Cash Flows Provided By (Used In):
Operating activities		$	23.5			$	21.6
Investing activities			(10.2	)			(18.1	)
Financing activities			(15.4	)			(49.7	)
Effect of exchange rate changes on cash			—				(0.6	)
Decrease in Cash and Cash Equivalents		$	(2.1	)		$	(46.8	)

Operating Activities

Cash provided by operating activities was driven primarily by net income, adjusted by non-cash expenses related to depreciation and amortization. The sources of cash were offset by changes in our working capital primarily driven by the payout of our performance based compensation and restructuring accruals related to our 2010 fiscal year and the timing of payments on our trade payables. The increase over the first quarter of fiscal 2010 was due to higher income offset by higher payouts of performance based compensation.

Investing Activities

Cash used for investing activities during the first quarter of fiscal 2011 decreased over the first quarter of fiscal 2010, driven primarily by the payment in the prior year period to acquire a 60 percent interest in our Encompass joint venture.

Financing Activities

Cash used for financing activities during the first quarter of fiscal 2011 consisted mainly of repurchasing shares, the purchase of the remaining 40 percent noncontrolling interest in our former Encompass joint venture and cash dividend payments, offset by cash received from stock option exercises. The decline in uses of cash compared to the first quarter of fiscal 2010 was due to the $45 million payment on our revolving credit facility in the first quarter of fiscal 2010 and cash proceeds from stock option exercises in the current year, partially offset by current year share repurchases and the purchase of the noncontrolling interest in our former Encompass joint venture.

Other Liquidity Matters

Net cash flows from operating activities and selected borrowings have represented our primary sources of funds for growth of the business, including capital expenditures and acquisitions.

As of December 31, 2010, we held investment securities with a fair value of $11.8 million, which consisted primarily of AAA rated student loan auction rate securities (“ARS”). We have estimated the current fair value of our ARS portfolio based upon guidance provided by our investment advisors, including consideration of the credit quality of the underlying securities and the provisions of the respective security agreements. At December 31, 2010, we have recorded temporary unrealized losses totaling $1.1 million on these securities to reflect the estimated decline in fair value associated with the current illiquidity in the auction rate market. If current market conditions do not improve or worsen the result could be further realized or unrealized losses or impairments, and liquidity and earnings could be adversely affected.

We have a $500.0 million five-year senior revolving credit facility with a syndicate of banks. The syndication group consists of 11 financial institutions, which we believe reduces our exposure to any one institution and should leave us with significant borrowing capacity in the event that any one of the institutions within the group is unable to comply with the terms of our agreement. As of December 31, 2010, we had outstanding borrowings of $45.0 and $5.8 million of outstanding, undrawn letters of credit under the facility, leaving $449.2 million of borrowing capacity available.

We also have trade finance credit lines and uncommitted letter of credit facilities. These lines are associated with the normal course of business and do not currently, nor have they historically, been of a material size to the overall business.

We have $95.8 million of senior notes outstanding at various fixed interest rates as of December 31, 2010. Of the total amount, $48.5 million are classified as long-term and $47.3 million short-term in the Condensed Consolidated Balance Sheet.

Our financing agreements contain no restrictive provisions or conditions relating to dividend payments, working capital or additional unsecured indebtedness (except to the extent that a dividend payment or incurrence of additional unsecured indebtedness would result in a default under our financing agreements), but there are limitations with respect to secured indebtedness. Our debt agreements also contain no credit rating triggers. Credit rating changes can, however, impact the cost of borrowings under our financing agreements. Additionally, we have restrictive covenants within the Distribution Agreement between us and Hillenbrand, Inc. This agreement has certain limitations on indebtedness, dividends and share repurchases and acquisitions. See Note 3 of Notes to Consolidated Financial Statements in our 2010 Form 10-K for more details on the Distribution Agreement.

Our pension plans invest in a variety of equity and debt securities. At September 30, 2010, our latest measurement date, our pension plans were underfunded by approximately $50.8 million. Given the significant funding contribution made during fiscal 2010, we currently do not anticipate any further contributions to our master pension plan in fiscal 2011.

As previously disclosed, we intend to continue to pay quarterly cash dividends comparable to those paid over the past two years. However, the declaration and payment of dividends by us will be subject to the sole discretion of our Board of Directors and will depend upon many factors, including financial condition, earnings, capital requirements, covenants associated with debt obligations, legal requirements and other factors deemed relevant by the Board of Directors.

We intend to continue to pursue selective acquisition candidates in certain areas of our business, but the timing, size or success of any acquisition effort and the related potential capital commitments cannot be predicted. We expect to fund future acquisitions primarily with cash on hand, cash flow from operations and borrowings, within our set limits. The Distribution Agreement discussed above contains certain restrictions with respect to additional indebtedness we may take on to make acquisitions. We do not anticipate, however, such restrictions will limit our ability to execute our current growth strategy.

As of December 31, 2010, we had authorization remaining to repurchase 1.4 million additional shares of our common stock. During the first quarter of fiscal 2011 we repurchased 0.6 million shares in addition to the 1.0 million shares purchased during the fourth quarter of fiscal 2010. Repurchased shares are used for general business purposes.

We believe that cash on hand and generated from operations, along with amounts available under our credit facility, will be sufficient to fund operations, working capital needs, capital expenditure requirements and financing obligations. However, disruption and volatility in the credit markets could impede our access to capital. If we need additional sources of capital, whether as a result of reduced cash generated by operations, unavailability of borrowings under our credit facility, adverse results in litigation matters or increased cash requirements to fund acquisitions and pension obligations, such sources of capital may not be available to us on acceptable terms, if at all.

Contractual Obligations and Contingent Liabilities and Commitments

There have not been any significant changes since September 30, 2010 impacting our contractual obligations and contingent liabilities and commitments.

Critical Accounting Policies

Our accounting policies require management to make significant estimates and assumptions using information available at the time the estimates are made. Such estimates and assumptions significantly affect various reported amounts of assets, liabilities, revenues and expenses. If future experience differs materially from these estimates and assumptions, our results of operations and financial condition could be affected. A detailed description of our accounting policies is included in Note 1 of Notes to Consolidated Financial Statements and the Critical Accounting Policies Section of Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our 2010 Form 10-K. There have been no material changes to such policies since September 30, 2010.

For a further summary of certain accounting policies and estimates and recently issued accounting pronouncements applicable to us, see Note 1 of Notes to Condensed Consolidated Financial Statements in this Form 10-Q.

Item 3.		QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS

We are exposed to various market risks, including fluctuations in interest rates, credit availability and the current economic downturn, liquidity issues with respect to auction rate securities, collection risk associated with our accounts and notes receivable portfolio and variability in currency exchange rates. We have established policies, procedures and internal processes governing our management of market risks and the use of financial instruments to manage our exposure to such risks.

We are subject to variability in foreign currency exchange rates in our international operations. Exposure to this variability is periodically managed primarily through the use of natural hedges, whereby funding obligations and assets are both managed in the local currency. We, from time-to-time, enter into currency exchange agreements to manage our exposure arising from fluctuating exchange rates related to specific and forecasted transactions. We operate this program pursuant to documented corporate risk management policies and do not enter into derivative transactions for speculative purposes. The sensitivity of earnings and cash flows to variability in exchange rates is assessed by applying an appropriate range of potential rate fluctuations to our assets, obligations and projected results of operations denominated in foreign currencies.

Our currency risk consists primarily of foreign currency denominated firm commitments and forecasted foreign currency denominated intercompany and third-party transactions. At December 31, 2010, the notional amount of open foreign exchange contracts was $12.7 million. The maximum length of time over which the Company is hedging transaction exposures is 15 months. Derivative gains/(losses), initially reported as a component of Accumulated Other Comprehensive Loss, are reclassified to earnings in the period when the transaction affects earnings.

For additional information on market risks related to our auction rate securities, debt instruments and pension plan assets, see Item 7A, Quantitative and Qualitative Disclosures About Market Risk, in our 2010 Form 10-K and Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations in this Form 10-Q.

Item 4.		CONTROLS AND PROCEDURES

Our management, with the participation of our President and Chief Executive Officer and our Senior Vice President and Chief Financial Officer (the “Certifying Officers”), has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of the end of the period covered by this report. Based upon that evaluation, the Certifying Officers concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report for the information required to be disclosed in the reports we file or submit under the Exchange Act to be recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and such information is accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosure. There were no changes in our internal control over financial reporting during the quarter ended December 31, 2010 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II — OTHER INFORMATION

Item 1.		LEGAL PROCEEDINGS

No material legal proceedings developed, and no material developments to prior reported legal proceedings occurred, during the reporting period.

Item 1A.		RISK FACTORS

For information regarding the risks we face, see the discussion under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended September 30, 2010. There have been no material changes to the risk factors described in that report.

Item 2.		UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

										Total Number of
										Shares Purchased as				Maximum Number of
		Total Number								Part of Publicly				Shares that May Yet
		of Shares				Average Price Paid				Announced Plans or				Be Purchased Under
Period		Purchased (1)				per Share				Programs (2)				Plans or Programs
October 1, 2010 - October 31, 2010			—			$	—				—				2,000,000
November 1, 2010 - November 30, 2010			212,554				39.37				212,500				1,787,500
December 1, 2010 - December 31, 2010			488,012				41.95				402,500				1,385,000
Total			700,566			$	41.16				615,000				1,385,000

Item 6.		EXHIBITS

A.

Exhibits

	10.1	*		2011 Non-Employee Director Compensation Policy (Incorporated by reference to Exhibit 10.61 filed with the Company’s Form 10-K on November 17, 2010)
	10.2	*		Form of Non-Qualified Stock Option Agreement under Amended and Restated Hill-Rom Holdings, Inc. Stock Incentive Plan (Incorporated by reference to Exhibit 10.62 filed with the Company’s Form 10-K on November 17, 2010)
	10.3	*		Form of Restricted Stock Unit Agreement under Amended and Restated Hill-Rom Holdings, Inc. Stock Incentive Plan (Incorporated by reference to Exhibit 10.63 filed with the Company’s Form 10-K on November 17, 2010)
	10.4	*		Form of Non-Qualified Stock Option Agreement (CEO version) under Amended and Restated Hill-Rom Holdings, Inc. Stock Incentive Plan (Incorporated by reference to Exhibit 10.64 filed with the Company’s Form 10-K on November 17, 2010)
	10.5	*		Form of Restricted Stock Unit Agreement (CEO version) under Amended and Restated Hill-Rom Holdings, Inc. Stock Incentive Plan (Incorporated by reference to Exhibit 10.65 filed with the Company’s Form 10-K on November 17, 2010)
	10.6	*		FY 2011 Form of Performance Based Stock Award under the Stock Incentive Plan
	10.7	*		FY 2011 Form of Performance Based Stock Award under the Stock Incentive Plan (CEO version)
	10.8	*		Employment Agreement between Hill-Rom Holdings, Inc. and Mark Guinan, dated November 1, 2010 (Incorporated by reference to Exhibit 10.1 filed with the Company’s Form 8-K on November 1, 2010)
	10.9	*		Limited Recapture Agreement between Hill-Rom Holdings, Inc. and Mark Guinan, dated November 1, 2010 (Incorporated by reference to Exhibit 10.2 filed with the Company’s Form 8-K on November 1, 2010)
	10.10	*		Letter Agreement between Hill-Rom Holdings, Inc. and Greg Miller, dated November 1, 2010 (Incorporated by reference to Exhibit 10.4 filed with the Company’s Form 8-K on November 1, 2010)
	10.11	*		Separation and Release Agreement between Hill-Rom Holdings, Inc. and Perry Stuckey effective December 31, 2010
	10.12	*		Employment Agreement between Hill-Rom Holdings, Inc. and Brian Lawrence, dated December 6, 2010
	10.13	*		Limited Recapture Agreement between Hill-Rom Holdings, Inc. and Brian Lawrence, dated December 6, 2010
	31.1			Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
	31.2			Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
	32.1			Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
	32.2			Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS				XBRL Instance Document
101.SCH				XBRL Taxonomy Extension Schema Document
101.CAL				XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB				XBRL Extension Labels Linkbase Document
101.PRE				XBRL Taxonomy Extension Presentation Linkbase Document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.